A Little Girl's Courage: From a Strange Limp to Beating Bone Cancer
What started as a funny, long-legged skip in a Sydney toddler turned into a harrowing battle against a rare bone cancer. Now, as she approaches her fifth birthday, Mileah Hennessy is thriving, and her family is sharing their story to help raise vital funds for childhood cancer research.
Kelly Hennessy first thought her daughter Mileah was just copying her older cousin's playful, unusual skip. The energetic two-and-a-half-year-old loved the outdoors and her close-knit family. When daycare reported that Mileah was dragging one side after a minor fall, her mother suspected a sprain and moved up a doctor's appointment. Nothing prepared her for what came next.
An X-Ray Reveals a Dark Mass
An X-ray showed a large dark mass around Mileah's left knee and femur. A pediatrician told Ms. Hennessy it was either an infection or a tumor. The first biopsy was inconclusive, and after two agonizing weeks, a second biopsy confirmed the worst: osteosarcoma, a rare and aggressive bone cancer.
Ms. Hennessy described the moment to AAP with raw honesty:
“I've never had a feeling like it. You know how you get that sick feeling or a nervous feeling? It's like that. It was accompanied with complete sadness and fear.”
Brutal Treatment and a Bold Surgery
Because of Mileah's young age and the tumor's position, amputation was raised early as a possibility. Within days, she had a central line inserted and began chemotherapy. The treatment was brutal, bringing fevers, vomiting, mucositis, and repeated hospitalizations. Her regime included doxorubicin, a drug so toxic it is nicknamed the “red devil.”
After two cycles of chemo, Mileah traveled to Melbourne for a Van Ness rotationplasty, a rare limb-salvage procedure. Surgeons removed part of her leg, rotated her foot 180 degrees, and attached it to her thigh. Her heel now functions as a knee joint inside a prosthetic leg.
For Ms. Hennessy, the hardest part was returning home and watching her daughter deteriorate as chemo continued.
“That was when all the infections came. That was when she was on a lot of different drips for medication and for pain tolerance.”
Life Goes On: The Family's Struggle
The experience consumed the family's life. Ms. Hennessy stopped working, faced financial pressures, and saw friendships change and her relationship break down.
“Life still goes on. You've got your financial issues because you're not working. There's all these little things that still are going on around the outside but your focus is just on making sure your kid gets better.”
To help Mileah understand, she kept it simple:
“You've got a leg that's very sick, we need to get it better, we've got to give you special medicine but then we're going to give you a new leg.”
Thriving Today, Looking to the Future
Now approaching her fifth birthday, Mileah has finished treatment and is thriving. She is back at preschool, preparing for kindergarten, and already on her third prosthetic leg. She walks almost normally and is working on running and riding a bike. Her latest lung scans were clear.
Ms. Hennessy hopes Mileah will remember little of the worst parts. Instead, her daughter is busy choosing colorful patterns for her prosthetic, from mermaids to Barbie and Disney characters. Her young age may mean she will never remember life without a prosthetic leg.
A Boost for Australian Cancer Research
In good news for other young Australians, the government recently committed $5 million to support Australian participation in the LifeArc Worldwide CAR-T Pathfinder Trial and Paediatric Cell Therapy Accelerator. CAR-T is an immunotherapy that re-engineers a patient's white blood cells to destroy cancer cells.
Health Minister Mark Butler said the funding
“will help bring world-class international CAR-T clinical trials closer to home for Australian children and young people with cancer.”The funding is part of a $300 million investment in the Australian Cancer Research Program.
Professor Brendan Murphy, chair of Children's Cancer CoLab, welcomed the announcement. The CoLab reports that 1,000 Australian kids are diagnosed with cancer every year, three die every week, and 80% of survivors have long-term effects from treatment.
Dare to Cure: Putting CEOs Outside Their Comfort Zone
Mileah's family is now sharing her story to boost corporate involvement in the fight against cancer. The 2025 Dare to Cure events in Sydney and Melbourne raised $1.7 million, funding the equivalent of 16 senior researchers. The CEO Dare to Cure event, run by the Children's Cancer Institute, challenges business leaders to step outside their comfort zones while raising money.
Chris Dutton, founder of CEO Magazine and an ambassador for the event, said:
“CEO Dare to Cure is the number one event that any CEO or leader should seriously consider doing. It's a chance to come together to help children with cancer. There's nothing better really.”
For Ms. Hennessy, the campaign is about more than funds. Children facing cancer are pushed outside their comfort zones every day, through scans, chemo, surgeries, and hospital stays. Asking fortunate people to challenge themselves, even briefly, fosters empathy as well as money.
“It makes an incredible difference because these kids are getting put out of their comfort zone every single day, 24-7. To have such an amazing campaign where you can have a laugh and raise money at the same time and also watch people being put out of their comfort zone in a safe and welcome environment, I think makes a huge difference.”
Mileah's story is a reminder of the resilience of children and the power of community. For families in the Philippines facing similar battles, it echoes the ongoing need for better access to cancer care and research funding, a cause that transcends borders.